1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,438 | 0,476 | 21.08. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | ORBUSNEICH (06929): CHANGE OF OFFICERS AND COMPANY SECRETARY | 1 | HKEx | ||
| 14.08. | ORBUSNEICH (06929): DECLARATION OF INTERIM DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS (UPDATED) | 1 | HKEx | ||
| 13.08. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Reports Growth Across All Geographies in 2026 Interim Results | 2.496 | JCN Newswire | - Revenue Up 18.1% to US$98.7 Million- Net Profit Rises to US$21.6 Million- Declares First Interim Dividend of HK8 Cents Per ShareHONG KONG, Aug 13, 2026 - (ACN Newswire) - Results Highlights:- Revenue... ► Artikel lesen | |
| 13.08. | OrbusNeich Medical Group Holdings Limited H1 Profit Climbs | 5 | RTTNews | ||
| 13.08. | ORBUSNEICH Interim Net Profit Rises 9% YoY to USD21.57 million; Interim DPS HKD0.08 | 2 | AASTOCKS | ||
| ORBUSNEICH MEDICAL GROUP Aktie jetzt für 0€ handeln | |||||
| 13.08. | ORBUSNEICH (06929): DECLARATION OF INTERIM DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS | 6 | HKEx | ||
| 13.08. | ORBUSNEICH (06929): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2026 | 2 | HKEx | ||
| 31.07. | ORBUSNEICH (06929): DATE OF BOARD MEETING | 1 | HKEx | ||
| 24.07. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Announces Enrollment of First Patient in Japan Clinical Trial for its Proprietary Drug-Coated Balloon | 649 | JCN Newswire | HONG KONG, July 22, 2026 - (ACN Newswire) - OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group' stock code: 6929), a multinational medical device company specializing in interventional... ► Artikel lesen | |
| 22.07. | ORBUSNEICH (06929): VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLMENT IN JAPAN CLINICAL TRIAL FOR ITS PROPRIETARY DRUG-COATED BALLOON | 1 | HKEx | ||
| 09.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 09.06.2026 | 787 | Xetra Newsboard | Das Instrument G85 CA35958L1013 FUERTE METALS CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 09.06.2026 und ex Kapitalmassnahme am 10.06.2026 The instrument G85 CA35958L1013 FUERTE METALS CORP.... ► Artikel lesen | |
| 08.06. | ORBUSNEICH (06929): (1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 8, 2026 AND (2) PAYMENT OF FINAL DIVIDEND | 1 | HKEx | ||
| 13.04. | ORBUSNEICH (06929): REMINDER LETTER TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT AND CIRCULAR INCLUDING NOTICE OF ANNUAL ... | 1 | HKEx | ||
| 13.04. | ORBUSNEICH (06929): REMINDER LETTER TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT, CIRCULAR INCLUDING NOTICE OF ANNUAL GENERAL ... | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON JUNE 8, 2026 | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): (1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS, (2) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES, (3) ... | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | 2 | HKEx | ||
| 13.04. | ORBUSNEICH (06929): ANNUAL REPORT 2025 | 2 | HKEx | ||
| 12.03. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Achieves Record-breaking Revenue, Sales Volume and Gross Profit in FY2025, Net Profit Rises to US$42 million, Final Dividend Increases by 20% to HK12 Cents per Share | 788 | JCN Newswire | - Sharpens Competitive Edge in Commercialization and Product Innovation- While Exploring New Business Models for Sustainable GrowthHONG KONG, Mar 12, 2026 - (ACN Newswire) - Results Highlights:- Revenue... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,140 | -1,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 46,600 | +0,83 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,200 | +0,98 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| HEARTFLOW | 49,750 | 0,00 % | Heartflow Aktie auf Rekordhoch: Kurs steigt auf 48,7 USD | ||
| LIFESTANCE HEALTH GROUP | 12,470 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,170 | +0,08 % | Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight | ||
| PROGYNY | 25,650 | 0,00 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,84 | -0,05 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 95,20 | +0,18 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,480 | +1,06 % | Milliardenmarkt Augengesundheit: Warum EssilorLuxottica und Carl Zeiss Meditec auf neue Technologien setzen - und wo Rise Nano Optics ins Spiel kommt | ||
| GENEDX | 87,05 | 0,00 % | GeneDx launches online exome testing for pediatric patients | ||
| ALIGNMENT HEALTHCARE | 13,165 | +0,04 % | Alignment Healthcare files motion to dismiss whistleblower lawsuit | ||
| SANARA MEDTECH | 34,430 | -0,06 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,120 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 21,670 | -0,05 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |
ORBUSNEICH MEDICAL GROUP HOLDINGS LTD gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,378 Euro und damit -1,05 % im Minus. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ORBUSNEICH MEDICAL GROUP HOLDINGS LTD finden Sie auf Wallstreet Online.